Key pathways, including the classic PINK1-Parkin and the hypoxia-driven BNIP3/Nix and FUNDC1 pathways, are implicated in the metabolic reconfiguration of cancer cells, particularly affecting glycolysis. The gene discussed is PRKN; the disease is cancer.